Higher antibody level correlates with greater vaccine protection against COVID-19

By | November 24, 2021
By measuring antibodies against the SARS-CoV-2 spike protein in participants in a phase 3 trial of the Moderna COVID-19 vaccine, researchers found that the higher the antibody level, the greater the vaccine protection against COVID-19.